Skip to main content

Pharming Group N.V.

PHAR
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0001828316

No open-market purchases or sales by Pharming Group N.V. insiders were filed in the last 90 days; 16 institutions reported holding it in 13F filings for Q2 2026, worth $1.31M in total; no superinvestor holds it.

Q3 2022 vs. Q2 2022

How the institutions holding Pharming Group N.V. changed between Q2 2022 and Q3 2022.

All holders in Q3 2022All holders in Q2 2022

13F holders of PHAR: Q2 2022 compared with Q3 2022
MeasureQ2 2022Q3 2022Change
Holders330
Shares20.5K25.0K+4.51K (+22.0%)
Value$180.0K$245.0K+$65.0K (+36.1%)

New holders (0)

Institutions that held Pharming Group N.V. at the end of Q3 2022 but not at the end of Q2 2022.

None.

Sold out (0)

Institutions that held Pharming Group N.V. at the end of Q2 2022 and filed for Q3 2022 without it.

None.